A new study conducted at Northwestern University Feinberg School of Medicine in Chicago has uncovered a link between men with inflammatory bowel disease and a subsequent higher risk of developing prostate cancer. According to lead author Dr. Shilajit Kundu, the study, conducted on over 1,000 men with inflammatory bowel disease, showed higher prostate-specific antigen (PSA) levels over long-term follow-up, levels representative of a 4-5 times more likely change of being diagnosed with prostate cancer.
To read more about this study, click here.
No comments:
Post a Comment